Back to Search
Start Over
Patterns and predictors of depressive and anxiety symptoms within a population-based sample of adults diagnosed with COVID-19 in Michigan.
- Source :
-
Social psychiatry and psychiatric epidemiology [Soc Psychiatry Psychiatr Epidemiol] 2023 Jul; Vol. 58 (7), pp. 1099-1108. Date of Electronic Publication: 2023 Mar 14. - Publication Year :
- 2023
-
Abstract
- Purpose: The COVID-19 pandemic has had wide-ranging impacts on mental health, however, less is known about predictors of mental health outcomes among adults who have experienced a COVID-19 diagnosis. We examined the intersection of demographic, economic, and illness-related predictors of depressive and anxiety symptoms within a population-based sample of adults diagnosed with COVID-19 in the U.S. state of Michigan early in the pandemic.<br />Methods: Data were from a population-based survey of Michigan adults who experienced a COVID-19 diagnosis prior to August 1, 2020 (Nā=ā1087). We used weighted prevalence estimates and multinomial logistic regression to examine associations between mental health outcomes (depressive symptoms, anxiety symptoms, and comorbid depressive/anxiety symptoms) and demographic characteristics, pandemic-associated changes in accessing basic needs (accessing food/clean water and paying important bills), self-reported COVID-19 symptom severity, and symptom duration.<br />Results: Relative risks for experiencing poor mental health outcomes varied by sex, age, race/ethnicity, and income. In adjusted models, experiencing a change in accessing basic needs associated with the pandemic was associated with higher relative risks for anxiety and comorbid anxiety/depressive symptoms. Worse COVID-19 symptom severity was associated with a higher burden of comorbid depressive/anxiety symptoms. "Long COVID" (symptom duration greater than 60 days) was associated with all outcomes.<br />Conclusion: Adults diagnosed with COVID-19 may face overlapping risk factors for poor mental health outcomes, including pandemic-associated disruptions to household and economic wellbeing, as well as factors related to COVID-19 symptom severity and duration. An integrated approach to treating depressive/anxiety symptoms among COVID-19 survivors is warranted.<br /> (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.)
- Subjects :
- Adult
Humans
COVID-19 Testing
Michigan
Pandemics
Anxiety
Depression
COVID-19
Subjects
Details
- Language :
- English
- ISSN :
- 1433-9285
- Volume :
- 58
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Social psychiatry and psychiatric epidemiology
- Publication Type :
- Academic Journal
- Accession number :
- 36917277
- Full Text :
- https://doi.org/10.1007/s00127-023-02453-9